Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: East Brunswick NJ, Providence RI, Toronto, Milwaukee WI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05875168
Phase 1, Phase 2, Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
for
Thyroid Eye Disease, TED, Graves Orbitopathy
Location: Somerset NJ, East Weymouth MA, Norfolk VA,
Sponsor: Sling Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07753603
Phase 3, Recruiting
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07611214
Recruiting
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
for
Alzheimer's Disease
Location: Neptune NJ, Winter Park FL, Brooksville FL, Marrero LA,
Sponsor: Cyclo Therapeutics, Inc.
Sex: All
Age: 50 - 70+
Code: NCT05607615
Phase 2, Recruiting
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
for
Infertility (IVF Patients), Oocyte Competence,
Location: Basking Ridge NJ
Sponsor: Reproductive Medicine Associates of New Jersey
Sex: Female
Age: 18 - 41
Code: NCT06629766
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Quantifying Uterine Elastography in Menstruating Women
for
Infertility (IVF Patients),
Location: Basking Ridge NJ
Sponsor: Reproductive Medicine Associates of New Jersey
Sex: Female
Age: 18 - 45
Code: NCT06816381
Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
for
AMI Cardiogenic Shock
Location: Neptune City NJ, York PA, Boston MA, Falls Church VA,
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT06964685
Recruiting
Discarded Materials Study
for
Infertility
Location: Basking Ridge NJ
Sponsor: Reproductive Medicine Associates of New Jersey
Sex: All
Age: 18 - 65
Code: NCT01219335
Recruiting
Platelet Rich Plasma for Insufficient Endometrium
for
Infertility of Uterine Origin
Location: Basking Ridge NJ
Sponsor: Reproductive Medicine Associates of New Jersey
Sex: Female
Age: 18 - 45
Code: NCT05538338
Recruiting
Male Infertility and Assisted Reproductive Technologies Research Biobank
for
Male Infertility, Infertility (IVF Patients)
Location: Basking Ridge NJ
Sponsor: Reproductive Medicine Associates of New Jersey
Sex: Male
Age: 0+
Code: NCT06880302
Recruiting
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
for
Metastatic Prostate Cancer
Location: East Brunswick NJ
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07529717
Phase 1, Phase 2, Recruiting
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
for
Primary Mitochondrial Disease
Location: Marlboro NJ, Pittsburgh PA, Akron OH, Atlanta GA,
Sponsor: Pharming Technologies B.V.
Sex: All
Age: 18+
Code: NCT05650229
Phase 2, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
for
Glioblastoma
Location: Valhalla NY, Neptune City NJ, Providence RI,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT07195591
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
for
Amyloidosis
Location: Hackensack NJ, New Haven CT, Boston MA, Nashville TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07224672
Phase 2, Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age